Skip to main content
Top
Gepubliceerd in: Netherlands Heart Journal 10/2011

01-10-2011 | Original Article

A comparison of clinical outcomes of Chinese sirolimus-eluting stents versus foreign sirolimus-eluting stents for the treatment of coronary artery disease

Auteurs: M. Yu, Y.-J. Zhou, Z.-J. Wang, D.-M. Shi, Y.-Y. Liu, Y.-X. Zhao, Y.-H. Guo, W.-J. Cheng, Y.-P. Li, H.-Y. Ma

Gepubliceerd in: Netherlands Heart Journal | Uitgave 10/2011

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Background

Chinese sirolimus-eluting stents (SES) have been widely used in recent years. However, the comparison of clinical outcomes between Chinese and foreign SES remains unknown.

Objectives

To compare the outcomes of Chinese SES (Firebird) with foreign SES (Cypher Select) in the treatment of patients undergoing percutaneous coronary intervention (PCI).

Methods

4000 consecutive patients treated with SESs from January 2008 to December 2009 were included in this study. Based on the differences of the stents, the patients were divided into a Chinese SES group (Firebird; n = 2008) and a foreign SES group (Cypher Select; n = 1992). Outcomes were monitored for 1 year. The primary clinical endpoint was major adverse cardiac events (MACE): a composite of death, non-fatal myocardial infarction (MI) and target-vessel revascularisation (TVR).

Results

No differences were observed in the incidence of MACE (17.8% vs. 18.6%, p = 0.514) and TVR rate (9.0% vs. 8.6%, p = 0.632) during 1-year follow-up.

Conclusions

Chinese SES and foreign SES have similar effects on 1-year clinical outcomes and safety.
Literatuur
1.
go back to reference Bental T, Assali A, Vaknin-Assa H, et al. A comparative analysis of major clinical outcomes using drug-eluting stents versus bare-metal stents in a large consecutive patient cohort. Catheter Cardiovasc Interv. 2010;76(3):374–80.PubMedCrossRef Bental T, Assali A, Vaknin-Assa H, et al. A comparative analysis of major clinical outcomes using drug-eluting stents versus bare-metal stents in a large consecutive patient cohort. Catheter Cardiovasc Interv. 2010;76(3):374–80.PubMedCrossRef
2.
go back to reference Schomig A, Dibra A, Windecker S, et al. A meta-analysis of 16 randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in patients with coronary artery disease. J Am Coll Cardiol. 2007;50(14):1373–80.PubMedCrossRef Schomig A, Dibra A, Windecker S, et al. A meta-analysis of 16 randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in patients with coronary artery disease. J Am Coll Cardiol. 2007;50(14):1373–80.PubMedCrossRef
3.
go back to reference Beijk MA, Koch KT, Tijssen JG, et al. A retrospective analysis of consecutive patients undergoing nonurgent percutaneous coronary intervention comparing bare metal stents with drug-eluting stents using the National Institute for Clinical Excellence criteria. Coron Artery Dis. 2010 2010-11-02. Beijk MA, Koch KT, Tijssen JG, et al. A retrospective analysis of consecutive patients undergoing nonurgent percutaneous coronary intervention comparing bare metal stents with drug-eluting stents using the National Institute for Clinical Excellence criteria. Coron Artery Dis. 2010 2010-11-02.
4.
go back to reference Ferreira E, Araujo DV, Azevedo VM, et al. Analysis of the cost-effectiveness of drug-eluting and bare-metal stents in coronary disease. Arq Bras Cardiol. 2010;94(3):286–92. 306–12.PubMedCrossRef Ferreira E, Araujo DV, Azevedo VM, et al. Analysis of the cost-effectiveness of drug-eluting and bare-metal stents in coronary disease. Arq Bras Cardiol. 2010;94(3):286–92. 306–12.PubMedCrossRef
5.
go back to reference Cheng JM, Onuma Y, Piazza N, et al. Comparison of five-year outcome of octogenarians undergoing percutaneous coronary intervention with drug-eluting versus bare-metal stents (from the RESEARCH and T-SEARCH Registries). Am J Cardiol. 2010;106(10):1376–81.PubMedCrossRef Cheng JM, Onuma Y, Piazza N, et al. Comparison of five-year outcome of octogenarians undergoing percutaneous coronary intervention with drug-eluting versus bare-metal stents (from the RESEARCH and T-SEARCH Registries). Am J Cardiol. 2010;106(10):1376–81.PubMedCrossRef
6.
go back to reference Hirlekar R, Patel M, Jain S, et al. Drug eluting coronary artery stents. Curr Drug Deliv. 2010 2010-10-26. Hirlekar R, Patel M, Jain S, et al. Drug eluting coronary artery stents. Curr Drug Deliv. 2010 2010-10-26.
7.
go back to reference Martin DM, Boyle FJ. Drug-eluting stents for coronary artery disease: A review. Med Eng Phys. 2010 2010-11-12. Martin DM, Boyle FJ. Drug-eluting stents for coronary artery disease: A review. Med Eng Phys. 2010 2010-11-12.
8.
go back to reference Park KW, Kang SH, Chung WY, et al. ‘Real world’ comparison of drug-eluting stents vs bare metal stents in the treatment of unselected patients with acute ST-segment elevation myocardial infarction. Circ J. 2010;74(6):1111–20.PubMedCrossRef Park KW, Kang SH, Chung WY, et al. ‘Real world’ comparison of drug-eluting stents vs bare metal stents in the treatment of unselected patients with acute ST-segment elevation myocardial infarction. Circ J. 2010;74(6):1111–20.PubMedCrossRef
9.
go back to reference Stone GW, Parise H, Witzenbichler B, et al. Selection criteria for drug-eluting versus bare-metal stents and the impact of routine angiographic follow-up: 2-year insights from the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial. J Am Coll Cardiol. 2010;56(19):1597–604.PubMedCrossRef Stone GW, Parise H, Witzenbichler B, et al. Selection criteria for drug-eluting versus bare-metal stents and the impact of routine angiographic follow-up: 2-year insights from the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial. J Am Coll Cardiol. 2010;56(19):1597–604.PubMedCrossRef
10.
go back to reference Spaulding C, Rosencher J, Varenne O. Use of drug eluting stents in ST segment elevation myocardial infarction. Heart. 2010;96(13):1073–7.PubMedCrossRef Spaulding C, Rosencher J, Varenne O. Use of drug eluting stents in ST segment elevation myocardial infarction. Heart. 2010;96(13):1073–7.PubMedCrossRef
11.
go back to reference Ma YC, Zuo L, Chen JH, et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol. 2006;17(10):2937–44.PubMedCrossRef Ma YC, Zuo L, Chen JH, et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol. 2006;17(10):2937–44.PubMedCrossRef
12.
go back to reference Cannon CP, Battler A, Brindis RG, et al. American College of Cardiology key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes. A report of the American College of Cardiology Task Force on Clinical Data Standards (Acute Coronary Syndromes Writing Committee). J Am Coll Cardiol. 2001;38(7):2114–30.PubMedCrossRef Cannon CP, Battler A, Brindis RG, et al. American College of Cardiology key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes. A report of the American College of Cardiology Task Force on Clinical Data Standards (Acute Coronary Syndromes Writing Committee). J Am Coll Cardiol. 2001;38(7):2114–30.PubMedCrossRef
13.
go back to reference Mauri L, Hsieh WH, Massaro JM, et al. Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med. 2007;356(10):1020–9.PubMedCrossRef Mauri L, Hsieh WH, Massaro JM, et al. Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med. 2007;356(10):1020–9.PubMedCrossRef
14.
go back to reference Liu HB, Xu B, Gao RL, et al. Outcomes of using Firebird rapamycin eluting stents in routine coronary intervention practice: one-year results from the pilot study of Firebird in China registry. Chinese Med J-Peking. 2006 2006-06-16(7):609–11. Liu HB, Xu B, Gao RL, et al. Outcomes of using Firebird rapamycin eluting stents in routine coronary intervention practice: one-year results from the pilot study of Firebird in China registry. Chinese Med J-Peking. 2006 2006-06-16(7):609–11.
15.
go back to reference Xu B. Sirolimus-eluting cobalt-chromium stents: two-year clinical results from first-in-man study on the Firebird stent. Chin Med J. 2008;121(6):492–7.PubMed Xu B. Sirolimus-eluting cobalt-chromium stents: two-year clinical results from first-in-man study on the Firebird stent. Chin Med J. 2008;121(6):492–7.PubMed
16.
go back to reference Chen F, Gao YC, He JQ, et al. A comparison of clinical outcomes after domestic sirolimus-eluting stents versus foreign sirolimus-eluting stents for the treatment of coronary artery disease. Chin J Cardiol. 2006;34(11):994–9. Chen F, Gao YC, He JQ, et al. A comparison of clinical outcomes after domestic sirolimus-eluting stents versus foreign sirolimus-eluting stents for the treatment of coronary artery disease. Chin J Cardiol. 2006;34(11):994–9.
Metagegevens
Titel
A comparison of clinical outcomes of Chinese sirolimus-eluting stents versus foreign sirolimus-eluting stents for the treatment of coronary artery disease
Auteurs
M. Yu
Y.-J. Zhou
Z.-J. Wang
D.-M. Shi
Y.-Y. Liu
Y.-X. Zhao
Y.-H. Guo
W.-J. Cheng
Y.-P. Li
H.-Y. Ma
Publicatiedatum
01-10-2011
Uitgeverij
Bohn Stafleu van Loghum
Gepubliceerd in
Netherlands Heart Journal / Uitgave 10/2011
Print ISSN: 1568-5888
Elektronisch ISSN: 1876-6250
DOI
https://doi.org/10.1007/s12471-011-0177-2

Andere artikelen Uitgave 10/2011

Netherlands Heart Journal 10/2011 Naar de uitgave